Motion mapping in humans as a biomarker for psychiatric disorders

Neuropsychopharmacology. 2019 Jan;44(1):231-232. doi: 10.1038/s41386-018-0205-7.

Authors

Ipsit V Vahia^{1

2}, Brent P Forester^{3

4}

Affiliations

¹ McLean Hospital, Belmont, MA, USA. [email protected].
² Harvard Medical School, Boston, MA, USA. [email protected].
³ McLean Hospital, Belmont, MA, USA.
⁴ Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types

News

MeSH terms

Biomarkers
Humans
Mental Disorders / diagnosis*
Mental Disorders / physiopathology
Movement / physiology*

Substances

Biomarkers